227 related articles for article (PubMed ID: 36544695)
1. Spermine synthase (
Pan X; Xue L; Sun Y
Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
[TBL] [Abstract][Full Text] [Related]
2. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
Front Genet; 2023; 14():1041042. PubMed ID: 36936420
[No Abstract] [Full Text] [Related]
3. The expression and methylation of
Zhao Y; Zhao J; Zhong M; Zhang Q; Yan F; Feng Y; Guo Y
Front Genet; 2022; 13():982241. PubMed ID: 36204311
[No Abstract] [Full Text] [Related]
4. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
[TBL] [Abstract][Full Text] [Related]
5. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
6. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract][Full Text] [Related]
7. CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Chen K; Li L; Mao W; Shen D; Yao N; Zhang L
Ann Transl Med; 2021 Sep; 9(18):1443. PubMed ID: 34733995
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
Hu R; Lu M; She L
Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
[TBL] [Abstract][Full Text] [Related]
9. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Huang J; Liang B; Wang T
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis and Experimental Validation of FOXD2 as a Novel Potential Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
He H; Yuan F; Li Y; Pi G; Shi H; Li Y; Han G
Curr Comput Aided Drug Des; 2024 Apr; ():. PubMed ID: 38629358
[TBL] [Abstract][Full Text] [Related]
11. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
[TBL] [Abstract][Full Text] [Related]
12. Integrative network analysis reveals subtype-specific long non-coding RNA regulatory mechanisms in head and neck squamous cell carcinoma.
Li J; Wu T; Song K; Zhu L; Wang Y; Chen T; Wang X
Comput Struct Biotechnol J; 2023; 21():535-549. PubMed ID: 36659932
[TBL] [Abstract][Full Text] [Related]
13. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
[TBL] [Abstract][Full Text] [Related]
14. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
Liu S; Wang Z
Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
[TBL] [Abstract][Full Text] [Related]
15. LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function.
Tian X; Hu D; Wang N; Zhang L; Wang X
Front Genet; 2024; 15():1337525. PubMed ID: 38655053
[TBL] [Abstract][Full Text] [Related]
16. Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis.
Zheng D; Luo S; Wang S; Huang J; Zhou Y; Su L; Chen Z; Wang S; He W
Transl Cancer Res; 2022 Sep; 11(9):3050-3063. PubMed ID: 36237258
[TBL] [Abstract][Full Text] [Related]
17. Identifying the Therapeutic and Prognostic Role of the CD8+ T Cell-Related Gene ALDH2 in Head and Neck Squamous Cell Carcinoma.
Zhang H; Li Z; Zheng Y
Cancer Inform; 2022; 21():11769351221139252. PubMed ID: 36570380
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CD247 in patients with head and neck squamous cell carcinoma: bioinformatic analysis of TCGA database.
Lin P; Hu XL; Hu YY; Liu MY; Wang QY; Ding Y; Ye JC
Ann Transl Med; 2022 Sep; 10(17):923. PubMed ID: 36172089
[TBL] [Abstract][Full Text] [Related]
20. Identification of the Nerve-Cancer Cross-Talk-Related Prognostic Gene Model in Head and Neck Squamous Cell Carcinoma.
Li J; Xu Y; Peng G; Zhu K; Wu Z; Shi L; Wu G
Front Oncol; 2021; 11():788671. PubMed ID: 34912722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
